Lafayette Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Buy |
47,754
+40,725
| +579% | +$2.81M | 0.67% | 43 |
|
|
2025
Q1 | $488K | Buy |
7,029
+1,083
| +18% | +$75.2K | 0.1% | 93 |
|
|
2024
Q4 | $511K | Buy |
5,946
+1,946
| +49% | +$167K | 0.11% | 86 |
|
|
2024
Q3 | $476K | Hold |
4,000
| – | – | 0.1% | 90 |
|
|
2024
Q2 | $571K | Hold |
4,000
| – | – | 0.13% | 80 |
|
|
2024
Q1 | $514K | Hold |
4,000
| – | – | 0.12% | 82 |
|
|
2023
Q4 | $414K | Sell |
4,000
-1,000
| -20% | -$103K | 0.1% | 91 |
|
|
2023
Q3 | $455K | Hold |
5,000
| – | – | 0.12% | 85 |
|
|
2023
Q2 | $405K | Hold |
5,000
| – | – | 0.11% | 87 |
|
|
2023
Q1 | $398K | Hold |
5,000
| – | – | 0.11% | 88 |
|
|
2022
Q4 | $338K | Hold |
5,000
| – | – | 0.1% | 92 |
|
|
2022
Q3 | $249K | Hold |
5,000
| – | – | 0.08% | 103 |
|
|
2022
Q2 | $279K | Hold |
5,000
| – | – | 0.08% | 99 |
|
|
2022
Q1 | $278K | Hold |
5,000
| – | – | 0.07% | 105 |
|
|
2021
Q4 | $280K | Hold |
5,000
| – | – | 0.07% | 106 |
|
|
2021
Q3 | $240K | Hold |
5,000
| – | – | 0.07% | 109 |
|
|
2021
Q2 | $209K | Buy |
+5,000
| New | +$209K | 0.06% | 118 |
|